68. Interactive Panelist
Session: Interactive Session: Challenging Cases in Pediatric Infectious Diseases
Thursday, October 20, 2011: 2:46 PM
Room: Grand Ballroom (East-West)


Mary Anne Jackson, MD, FIDSA, Children's Mercy Hospitals and Clinics, Kansas City, MO

Mary Anne Jackson, MD is chief of the Pediatric Infectious Diseases Section at Children’s Mercy Hospitals & Clinics, Kansas City, Missouri and professor of pediatrics at the University of Missouri-Kansas City School of Medicine.
Dr. Jackson obtained her medical degree from the University of Missouri-Kansas City School of Medicine. She completed her residency at Children’s Hospital Medical Center in Cincinnati where she was recognized with the Samuel Dalinsky Memorial Award as the outstanding graduating resident. She completed her infectious diseases fellowship training at the University of Texas-Southwestern.
She is a past chair of the American Board of Pediatrics’ Subboard of Pediatric Infectious Diseases and currently serves as the subboard medical editor. She is board certified in Pediatrics and Pediatric Infectious Diseases, a member of the American Academy of Pediatrics, and the American Pediatric Society. She is a current member of PIDS Council and Training Programs Committee and the IDSA Education committee as well as a current member of the Committee on Infectious Diseases. She has served on the editorial boards of Healthy Kids, Concise Reviews in Pediatric Infectious Diseases and is a current member of the editorial board of the Pediatric Infectious Diseases Journal. Since 2000, she has been a regular contributor to Pediatric News.
Current research activities focus on prevention of hospital acquired infections, antibiotic resistance and immunization awareness and implementation and has authored over 100 publications. In 2002 she participated in the US Senate hearing on vaccine shortages and in 2005, was the recipient of the Award for Excellence in Immunization Education and Advocacy from the Mid America Immunization Coalition.



Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.